Literature DB >> 21199461

Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.

Beena Hameed, Hugh Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21199461     DOI： 10.1111/j.1756-185X.2010.01482.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  10 in total

Review 1.  Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review.

Authors:  Susan M Goodman; Bruce N Cronstein; Vivian P Bykerk
Journal:  Clin Exp Rheumatol       Date:  2014-12-23       Impact factor: 4.473

Review 2.  Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?

Authors:  Sujani Yadlapati; Petros Efthimiou
Journal:  Rheumatol Int       Date:  2016-03-02       Impact factor: 2.631

Review 3.  LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects.

Authors:  Pinar Borman; Gülseren Demir; Ferda Kaygısız; Muyesser Okumuş
Journal:  Open Rheumatol J       Date:  2014-09-03

4.  Methotrexate injection site reactions: Case report and literature review.

Authors:  Japsimran Kaur; Jeanette Zambito; Christopher T Richardson
Journal:  JAAD Case Rep       Date:  2022-03-26

5.  Nearly pain-free self-administration of subcutaneous methotrexate with an autoinjector: results of a phase 2 clinical trial in patients with rheumatoid arthritis who have functional limitations.

Authors:  Bruce Freundlich; Alan Kivitz; Jonathan S Jaffe
Journal:  J Clin Rheumatol       Date:  2014-08       Impact factor: 3.517

6.  Patient's experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis.

Authors:  J R Curtis; F Xie; D Mackey; N Gerber; A Bharat; T Beukelman; K G Saag; L Chen; B Nowell; S Ginsberg
Journal:  BMC Musculoskelet Disord       Date:  2016-09-26       Impact factor: 2.362

Review 7.  Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis.

Authors:  Gino Antonio Vena; Nicoletta Cassano; Florenzo Iannone
Journal:  Ther Clin Risk Manag       Date:  2018-01-09       Impact factor: 2.423

Review 8.  Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.

Authors:  Alfonso E Bello; Elizabeth L Perkins; Randy Jay; Petros Efthimiou
Journal:  Open Access Rheumatol       Date:  2017-03-31

Review 9.  Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability.

Authors:  Iviensan F Manalo; Kathleen E Gilbert; Jashin J Wu
Journal:  Psoriasis (Auckl)       Date:  2015-05-05

10.  Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate.

Authors:  James R O'Dell; Stanley B Cohen; J Carter Thorne; Joel Kremer
Journal:  Open Access Rheumatol       Date:  2018-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.